Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 17;16:7697–7709. doi: 10.2147/IJN.S331519

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Proliferation inhibition of iDPP/LACTB nanocomplexes on B16-F10 melanoma cells. (A) mRNA levels of LACTB gene in B16-F10 cells of the four groups after 48 h. (*p < 0.05, ***p < 0.001). (B) Cell proliferation inhibition rate of treatment detected by CCK8 assay after 48 h treatment. (***p < 0.001). (C and D) Images and analysis of colony formation test of B16-F10 cells after 7days’ treatment (*p < 0.05). (E and F) Cell cycle distribution of B16-F10 cells by flow cytometry. (**p < 0.01, ns, not significant).